Skip to main content
ANVS logo

ANVS · Annovis Bio, Inc. · Executive Compensation

Track ANVS — free
$1.21 +0.04 (+3.42%) At close · Oct 9
Market Cap
$51.55M
Shares
42.61M
Volume · Oct 9 521.9K Avg daily vol (3M) 880.06K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Maria Maccecchini $808,000
Mark Guerin $234,500
Fiscal 2024
Executive Total
Maria Maccecchini $2,327,667
Fiscal 2023
Executive Total
Maria Maccecchini $2,788,838
Henry Hagopian III $490,873
Fiscal 2022
Executive Total
Maria Maccecchini $2,654,429
Henry Hagopian III $1,417,257
Jeffrey McGroarty $964,259
Fiscal 2021
Executive Total
Maria Maccecchini $8,586,137
Jeffrey McGroarty $4,978,184
Henry Hagopian III —
Fiscal 2020
Executive Total
Maria Maccecchini $1,014,232
Jeffrey McGroarty $894,232
Fiscal 2019
Executive Total
Maria Maccecchini $120,000
Jeffrey McGroarty —
Fiscal 2018
Executive Total
Maria Maccecchini $155,165
Jeffrey McGroarty —

Executive changes

Person Change Filed
Mark Guerin Terminated 2026-03-25
Mark Guerin Appointed 2025-09-29
Andrew Walsh Resigned 2025-08-15
Andrew Walsh Appointed 2025-05-13
William Fricker Resigned 2025-03-27
William Fricker Appointed 2024-12-09
Henry Hagopian Resigned 2024-05-01
Jeffrey B. McGroarty Terminated 2022-09-12
Henry Hagopian III Appointed 2022-08-30
Key facts CIK 1477845 CUSIP 03615A108 13F (30d) 3 filings 3 filers Visit website Investor relations